Johnson Chemical Pharmaceutical Works Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Johnson Chemical Pharmaceutical Works.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth	36.3%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Could Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Have The Makings Of Another Dividend Aristocrat?

Mar 25

These 4 Measures Indicate That Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Using Debt Reasonably Well

Feb 18

Weak Financial Prospects Seem To Be Dragging Down Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Stock

Feb 01

Estimating The Fair Value Of Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747)

Jan 12

Is Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) An Attractive Dividend Stock?

Dec 25

Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Growing Earnings But Are They A Good Guide?

Dec 07

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Johnson Chemical Pharmaceutical Works has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TPEX:4747 - Analysts future estimates and past financials data (TWD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	607	80	104	137	N/A
9/30/2023	593	81	99	122	N/A
6/30/2023	572	83	62	103	N/A
3/31/2023	533	75	47	106	N/A
12/31/2022	495	65	30	90	N/A
9/30/2022	460	59	20	77	N/A
6/30/2022	434	53	36	78	N/A
3/31/2022	416	51	29	56	N/A
12/31/2021	411	49	15	52	N/A
9/30/2021	408	50	12	53	N/A
6/30/2021	413	51	-155	23	N/A
3/31/2021	412	56	-119	61	N/A
12/31/2020	424	64	-90	72	N/A
9/30/2020	445	72	-73	87	N/A
6/30/2020	438	71	78	93	N/A
3/31/2020	442	68	52	65	N/A
12/31/2019	425	64	56	72	N/A
9/30/2019	411	61	29	47	N/A
6/30/2019	410	59	36	53	N/A
3/31/2019	412	59	64	72	N/A
12/31/2018	412	57	61	68	N/A
9/30/2018	405	54	78	83	N/A
6/30/2018	407	58	60	65	N/A
3/31/2018	402	58	50	55	N/A
12/31/2017	395	60	36	40	N/A
9/30/2017	396	62	N/A	36	N/A
6/30/2017	381	58	N/A	41	N/A
3/31/2017	382	60	N/A	54	N/A
12/31/2016	392	63	N/A	68	N/A
9/30/2016	392	67	N/A	68	N/A
6/30/2016	395	70	N/A	81	N/A
3/31/2016	390	67	N/A	55	N/A
12/31/2015	380	62	N/A	42	N/A
9/30/2015	366	55	N/A	45	N/A
6/30/2015	370	62	N/A	50	N/A
3/31/2015	365	68	N/A	62	N/A
12/31/2014	362	72	N/A	83	N/A
9/30/2014	363	83	N/A	75	N/A
6/30/2014	343	74	N/A	73	N/A
3/31/2014	328	69	N/A	62	N/A
12/31/2013	314	66	N/A	79	N/A
9/30/2013	293	56	N/A	70	N/A
6/30/2013	283	60	N/A	65	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 4747's forecast earnings growth is above the savings rate (1%).

Earnings vs Market: Insufficient data to determine if 4747's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 4747's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 4747's revenue is forecast to grow faster than the TW market.

High Growth Revenue: Insufficient data to determine if 4747's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 4747's Return on Equity is forecast to be high in 3 years time

Johnson Chemical Pharmaceutical Works Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Full year 2023 earnings released: EPS: NT$2.24 (vs NT$2.16 in FY 2022)

New minor risk - Market cap size

Johnson Chemical Pharmaceutical Works Co., Ltd., Annual General Meeting, May 24, 2024

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: NT$0.45 (vs NT$0.64 in 3Q 2022)

New minor risk - Shareholder dilution

Second quarter 2023 earnings released: EPS: NT$0.75 (vs NT$0.48 in 2Q 2022)

New minor risk - Market cap size

Investor sentiment improves as stock rises 26%

Upcoming dividend of NT$2.00 per share at 2.5% yield

Investor sentiment improves as stock rises 17%

First quarter 2023 earnings released: EPS: NT$0.75 (vs NT$0.42 in 1Q 2022)

Investor sentiment improves as stock rises 16%

Full year 2022 earnings released: EPS: NT$2.16 (vs NT$1.64 in FY 2021)

Investor sentiment improves as stock rises 19%

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

No independent directors

Third quarter 2022 earnings released: EPS: NT$0.64 (vs NT$0.44 in 3Q 2021)

Second quarter 2022 earnings released: EPS: NT$0.48 (vs NT$0.43 in 2Q 2021)

Upcoming dividend of NT$1.45 per share

First quarter 2022 earnings released: EPS: NT$0.42 (vs NT$0.35 in 1Q 2021)

No independent directors

Full year 2021 earnings released: EPS: NT$1.64 (vs NT$2.12 in FY 2020)

Johnson Chemical Pharmaceutical Works Co., Ltd., Annual General Meeting, May 26, 2022

Third quarter 2021 earnings released: EPS NT$0.44 (vs NT$0.47 in 3Q 2020)

Upcoming dividend of NT$1.92 per share

First quarter 2021 earnings released: EPS NT$0.35 (vs NT$0.61 in 1Q 2020)

Could Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Have The Makings Of Another Dividend Aristocrat?

Full year 2020 earnings released: EPS NT$2.12 (vs NT$2.15 in FY 2019)

New 90-day high: NT$37.65

Johnson Chemical Pharmaceutical Works Co., Ltd., Annual General Meeting, May 17, 2021

These 4 Measures Indicate That Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Using Debt Reasonably Well

Weak Financial Prospects Seem To Be Dragging Down Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) Stock

New 90-day low: NT$36.80

Estimating The Fair Value Of Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747)

Is Johnson Chemical Pharmaceutical Works Co., Ltd. (GTSM:4747) An Attractive Dividend Stock?

Johnson Chemical Pharmaceutical Works (GTSM:4747) Is Growing Earnings But Are They A Good Guide?

Third quarter 2020 earnings released: EPS NT$0.47

New 90-day low - NT$37.55

New 90-day low - NT$38.10

First half earnings released

New 90-day low - NT$39.00

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies